What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Virus
- Cancer
Stephen K. Tyring focuses on Dermatology, Internal medicine, Immunology, Surgery and Virology.
His Dermatology research incorporates themes from Actinic keratosis and Disease, Pathology.
His Internal medicine study frequently draws connections to other fields, such as Gastroenterology.
In his study, Genital warts and Cidofovir is strongly linked to Sexually transmitted disease, which falls under the umbrella field of Immunology.
The Surgery study combines topics in areas such as Clinical trial, Case-control study, Pediatrics and Risk factor.
His Virology research includes elements of Molecular biology, Polymerase chain reaction and Hpv testing.
His most cited work include:
- Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials (236 citations)
- Tropical dermatology: Fungal tropical diseases (171 citations)
- Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study (170 citations)
What are the main themes of his work throughout his whole career to date?
Dermatology, Immunology, Virology, Internal medicine and Pathology are his primary areas of study.
In general Dermatology study, his work on Plaque psoriasis often relates to the realm of In patient, thereby connecting several areas of interest.
Immunology is closely attributed to Disease in his work.
Specifically, his work in Virology is concerned with the study of Shingles.
His Internal medicine study combines topics in areas such as Gastroenterology, Psoriasis and Surgery.
His Surgery study frequently draws connections between adjacent fields such as Famciclovir.
He most often published in these fields:
- Dermatology (33.02%)
- Immunology (23.28%)
- Virology (17.18%)
What were the highlights of his more recent work (between 2015-2021)?
- Dermatology (33.02%)
- Internal medicine (16.41%)
- Psoriasis (8.21%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Dermatology, Internal medicine, Psoriasis, Immunology and Virology.
His Dermatology research is multidisciplinary, relying on both Phases of clinical research and Lotion.
Stephen K. Tyring has included themes like Gastroenterology and Surgery in his Internal medicine study.
Stephen K. Tyring combines subjects such as Mucocutaneous zone, Antigen and Merkel cell polyomavirus with his study of Virology.
The concepts of his Adverse effect study are interwoven with issues in Lesion, Clinical trial and Incidence.
His Pathogenesis research integrates issues from Virus, Disease and Etiology.
Between 2015 and 2021, his most popular works were:
- Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials (236 citations)
- Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study (170 citations)
- Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study (88 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Virus
His main research concerns Internal medicine, Psoriasis, Dermatology, Adverse effect and Randomized controlled trial.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Surgery.
His research investigates the connection between Psoriasis and topics such as Adalimumab that intersect with issues in Dyslipidemia and Vascular disease.
His studies in Dermatology integrate themes in fields like Vaccine efficacy and Phases of clinical research.
The study incorporates disciplines such as Lesion, Clinical trial and Viral shedding in addition to Adverse effect.
His work deals with themes such as Severity of illness and Dosing, which intersect with Randomized controlled trial.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
